UBIFRANCE Ireland was at France Digitale Day!

UBIFRANCE Dublin - 16-juin-2014 13:18:55
  On the 11th of June 2014, UBIFRANCE Ireland took part of France Digitale Day #2, a major tech event gathering a digital ecosystem of 1000+ participants including Startups, business angels, VCs, groups etc. This event, hosted in Carreau du Temple in Paris, by France Digital Day team, was aiming at bringing together innovative start-ups as well as success stories within this industry such as Criteo or Air BnB. Different conferences were run throughout the day with inspirational speakers and debates. It was an amazing event! According to Rude Baguette, last year, France Digitale demonstrated yet again its ability to mobilize and inspire France’s tech ecosystem with their hugely successful first France Digitale Day , which welcomed over 800 participants and pretty much every key mover and shaker in France’s tech ecosystem. This year’s edition, #FDD2, was even more ambitious and successfull. “Thinking bottom-up and not top-down for more agility. Thinking globally to make digital economy the pillar of a strong European single market, and harmonize international rules and nurture cooperation. France Digitale’s ambition is to build the road to growth for French and European startups. Sky is the limit!” Marie & Olivier, the co-founders.   Sources: Trista Bridges (Rude Baguette), France Digitale Day.

The success of France in biotechnologies

Marine Vicenzotti - 03-avr.-2014 12:59:26
Even though biotechnologies may be a recent sector of business activity, France has succeeded in developing real know-how that is gaining international recognition.   When it comes to biotechnologies, the French are cutting edge. According to Leeme, the federation of French medical companies, today France numbers 388 biotechs in the health field in France. Biotech France, another French association for biotech companies, indicates that a third of these companies have been in existence for over 10 years. Yet the number of creations in this field is exponential. To get an idea, 50 companies were started in 2012. Unheard of! Proof that there is a real entrepreneurial effervescence when it comes to this research in France. Young start-ups for the most part, French biotechs are mainly Small Medium sized companies. Only 4% of them have over 100 employees. On average, they employ 22 people. As to the type of activity, most of the French companies specialized in human sciences with therapeutic products are concentrated on cancer treatments. “The French have developed a full-fledged know-how on cardio-vascular devices, infectious diseases, dermatology, blood diseases and for surgery,” explains Yves Germani, Ubifrance’s manager for the health sector in North America.   French enterprises don’t just do research; they discover! Altogether, the French biotech industry generated 261 Million Euros in turnover in 2011, compared with 186 Million in 2010. As for companies on the stock market, they generate 369 Million Euros in turnover. Concerning the pipeline, the expression used to indicate the number of molecules being developed, France is 4rth, behind the United Kingdom, Germany, Switzerland and Israel. Quite a solid ranking, but which should nevertheless be improved. When their results are examined in detail, we see that depending on the stage of development, French companies create more products in the pre-clinic phase, in other words, all those that have been carried out before the clinical trial with patients, which is completely logical. Between the start of development on a new medicine, a molecule and its release on the market can sometimes take up to 10 years. Unfortunately, the consequence of this is that a number of products fall by the wayside. To be noted, however, is one undeniable fact: since 2008, French companies have sold more and more products. To put it another way, as Yves Germani points out, French companies don’t just do research; they discover!”   An increase of 63% in investment Even more impressive than all the rest, French biotech companies tend to have smaller R&D budgets than their European and international competitors. Fortunately, the culture of venture capital is developing very quickly in this sector. To give the general picture, the funds raised by French biotechs have increased by 63,1% from 2009 to 2012, reaching 178 Million Euros. Since the year 2000, they have managed to raise 2.920 Billion Euros. Today, French companies are naturally turning towards international opportunities to find new partners and new financial leverage. The proof is that such Small Medium companies as Affilogic, MedinCell, Interactive Biosoftware, Imabiotech or even O4CP all have one thing in common: they all are reaching out with confidence to mature markets like the United States, Canada and Western Europe.   Photo: Yves GERMANI, Ubifrance New York, biotechnologies expert

Focus on Irish and British e-commerce markets

Celine Chevreux - 24-mars-2014 18:27:19
Twenty e-retailers and suppliers of solutions and services attended an information meeting on March 6th about internet retailing in the UK and Irish markets at Ubifrance offices located in Paris. During this event, UBIFRANCE Ireland and the British Association of e-retailing: IMRG (Interactive Media in Retail Group) highlighted the opportunities on these markets. With € 111 billion of online sales in 2013, Ireland and the UK bring lot of opportunities for French exporters. The participants asked many questions to the speakers. The most motivated ones have exposed their projects during individual interviews and they may register for BtoB meetings to be held in Dublin and London from September 16th to 18th. This event will allow them to meet the local service providers (lawyers, call centers, e- marketing agencies, and logistics) in order to extend their activities to those buoyant markets.  

Networking cocktail

KAJJI Myriam - 24-févr.-2014 15:55:40
On the 30 th of January, UBIFRANCE Ireland, the French Trade Commission in Ireland, had the pleasure of inviting the Franco-Irish business community to their annual networking cocktail in the Crypt of Christchurch. This event was the opportunity for Jim Rice, Chairman of the IFCC ( Ireland France Chamber of Commerce ), to illustrate the ongoing successful collaboration between the IFCC and UBIFRANCE Ireland with the upcoming signature of a convention between our two organisations. The “Grand Prix VIE” (International Internship Program Competition) was also launched during the evening with Yann Mazeman, Director of SERVIER Ireland, speaking on the benefits of the VIE (International Internship Program) for both companies and volunteers. Finally, Valentin Poussin, Sales Manager of Lacroix-Sofrel, spoke about his collaboration with UBIFRANCE following the success of the introduction to the Irish market of his products: data loggers and leak detection devices. The evening was the perfect opportunity for UBIFRANCE to thank its business partners for their trust and collaboration during the past year and to hope for continued business relationships between our two countries for 2014.

MEDICA-COMPAMED: French Pavilion

Marine Vicenzotti - 18-nov.-2013 12:52:40
The D-Day is getting closer! This Wednesday 20th of December will be the first day of Medica-Compamed, one of the biggest medical devices trade show. Let me remind you: UBIFRANCE will be hosting an extensive French pavilion with over 140 French businesses exhibiting. You can  click here   medica-compamed_2013  to access the full catalogue. UBIFRANCE Ireland will be on the show and would be delighted to introduce to any of these companies so please let us know if you are interested.:     Marine Vicenzotti E-mail: marine.vicenzotti @ Tel: +353 1 411 2110 +353 871 636416 Gaelle Leterrier Tel: +353 1 411 21 13

MEDICA-COMPAMED 2013: focus on IVD

Marine Vicenzotti - 21-oct.-2013 13:59:09
  MEDICA-COMPAMED 2013: focus on the IVD (In Vitro Diagnostic)   You are probably aware of MEDICA-COMPAMED! Taking place in Düsseldorf from the 20th to the 23rd of November , this trade show will display the latest technologies, trends and developments in medical devices field with over 140 French companies exhibiting. Among these, 2 businesses specialised in In Vitro Diagnostic and Immunoassay development are interested in the Irish market.   Bio-Evolution is an European company specialised in the In Vitro Diagnostic field and offering an extended range of parameters in different areas of molecular biology such as Bacteriology, Virology, Parasitology, Mycology, Oncology etc. This French company is looking for distributors selling to medical biology laboratories and/or selling to hospitals laboratories.   Diaclone has 27 years of experience in the Monoclonal Antibody and Immunoassay development; with a large product portfolio (ELISA, ELISport, DIAplex, FastELISA…), Diaclone has acquired an expertise and know-how in the field which makes them a trusted partner for custom product development & manufacture, Bulk & OEM product supply. Diaclone is looking for different types of partners on the Irish market such as distributors for their range of Immunology products and life sciences partners. Please click here for further information.   Our team is at your disposal for any queries you may have: Marine.vicenzotti at at  

French Pavilion at MEDICA-COMPAMED: focus on orthopedics implants

Marine Vicenzotti - 08-oct.-2013 10:43:47
Would you like to EXPAND YOUR BUSINESS? SEIZE GREAT OPPORTUNIES? MAXIMISE YOUR TIME?   To do so, read below! UBIFRANCE Ireland, the French Trade Commission, is hosting a French Pavilion at MEDICA-COMPAMED . From the 20th to the 23rd of November in Düsseldorf, the latest technologies, trends and developments will be displayed with over 140 French companies exhibiting. Within the French Pavilion, 22 companies are looking to expand to the Irish market and are keen to meet potential Irish partners at the show. In order to help Irish buyers target the expertise, services and products they are looking for, UBIFRANCE Ireland is organising B2B meetings for free. These French companies are specialised in various sectors. Today we will focus on the 4 experts in orthopaedic implants: Hyprevention : Implantable medical devices to prevent or treat hip fractures Kisco : Implants and instruments for spine surgery Noraker : Synthetic and absorbable biomaterial-based implantable medical devices for bone substitution and osteosynthesis Spineway : Implants and instruments for spinal column surgery Please CLICK HERE for further details on these companies. Feel free to contact UBIFRANCE’s team if you require any further information: Marine Vicenzotti 01 411 2110 marine.vicenzotti at Gaelle Leterrier 01 411 2122 at
About Us
Business France, the French Trade Commission in Dublin, is the trade section of the French Embassy in Ireland. Our bicultural team comprises 7 motivated professionals, dedicated to the promotion of the trade between Ireland and France, helping the Irish trade to source products from France and French exporters to find Irish partners. Our office is organised in business sectors: -     Agribusiness , -     Fashion, Housing, Healthcare , -     Infrastructure, Transport, Industry, -     ICT, Innovation, Services, Please click here to view our organigram. We organise Trade Events on a yearly planning, for which you may participate and register your interest. Furthermore, we are in a position to help you source products from France on an individual basis. If you are looking for French suppliers, please contact us or visit the French Exporters Directory ( )   Busine


Press area & Media Gallery